5-ALA-Induced Fluorescent Urine Cytology in Comparison with Conventional Cytology, BTA-TRAK, and NMP-22 Tests in the Diagnosis of Bladder Cancer
Introduction To assess the sensitivity fluorescent urine cytology induced by 5-aminolevulinic acid (5-ALA) in the diagnosis of bladder cancer and to compare the sensitivity and specificity with currently available markers approved by the United States Food and Drug Administration (FDA), b...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sociedade Brasileira de Oncologia Clínica, Sociedade Brasileira de Cirurgia Clínica and Sociedade Brasileira de Radioterapia
2025-01-01
|
| Series: | Brazilian Journal of Oncology |
| Subjects: | |
| Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1791752 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841550859190665216 |
|---|---|
| author | Rajendra B Nerli Shadab Rangrez Shridhar C. Ghagane Parth Lalakia Shoubhik Chandra Shreya Chandra |
| author_facet | Rajendra B Nerli Shadab Rangrez Shridhar C. Ghagane Parth Lalakia Shoubhik Chandra Shreya Chandra |
| author_sort | Rajendra B Nerli |
| collection | DOAJ |
| description |
Introduction To assess the sensitivity fluorescent urine cytology induced by 5-aminolevulinic acid (5-ALA) in the diagnosis of bladder cancer and to compare the sensitivity and specificity with currently available markers approved by the United States Food and Drug Administration (FDA), bladder tumour antigen (BTA-TRAK, Bard Diagnostic Sciences, Redmond, WA, United States) assay based on enzyme-linked immunosorbent assay (ELISA), nuclear matrix protein 22 (NMP-22), and conventional cytology. |
| format | Article |
| id | doaj-art-90060e66c3cc4a36959f9d68643d3a9e |
| institution | Kabale University |
| issn | 2526-8732 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Sociedade Brasileira de Oncologia Clínica, Sociedade Brasileira de Cirurgia Clínica and Sociedade Brasileira de Radioterapia |
| record_format | Article |
| series | Brazilian Journal of Oncology |
| spelling | doaj-art-90060e66c3cc4a36959f9d68643d3a9e2025-01-09T23:53:46ZengSociedade Brasileira de Oncologia Clínica, Sociedade Brasileira de Cirurgia Clínica and Sociedade Brasileira de RadioterapiaBrazilian Journal of Oncology2526-87322025-01-012110.1055/s-0044-17917525-ALA-Induced Fluorescent Urine Cytology in Comparison with Conventional Cytology, BTA-TRAK, and NMP-22 Tests in the Diagnosis of Bladder CancerRajendra B Nerli0https://orcid.org/0000-0002-6099-0208Shadab Rangrez1Shridhar C. Ghagane2https://orcid.org/0000-0001-8959-3209Parth Lalakia3Shoubhik Chandra4Shreya Chandra5Department of Urology and Urologic Oncology, Jawaharlal Nehru Medical College, KLE Academy of Higher Education and Research (Deemed-to-be-University), Belagavi, Karnataka, IndiaDepartment of Urology and Urologic Oncology, Jawaharlal Nehru Medical College, KLE Academy of Higher Education and Research (Deemed-to-be-University), Belagavi, Karnataka, IndiaDr. Prabhakar Kore Basic Science Research Centre, KLE Academy of Higher Education and Research (Deemed-to-be-University), Belagavi, Karnataka, IndiaCollege of Population Health, Office of Global Affairs, Thomas Jefferson University, Philadelphia, United StatesDepartment of Urology and Urologic Oncology, Jawaharlal Nehru Medical College, KLE Academy of Higher Education and Research (Deemed-to-be-University), Belagavi, Karnataka, IndiaDepartment of Pathology, Jawaharlal Nehru Medical College, KLE Academy of Higher Education and Research (Deemed-to-be-University), Belagavi, Karnataka, India Introduction To assess the sensitivity fluorescent urine cytology induced by 5-aminolevulinic acid (5-ALA) in the diagnosis of bladder cancer and to compare the sensitivity and specificity with currently available markers approved by the United States Food and Drug Administration (FDA), bladder tumour antigen (BTA-TRAK, Bard Diagnostic Sciences, Redmond, WA, United States) assay based on enzyme-linked immunosorbent assay (ELISA), nuclear matrix protein 22 (NMP-22), and conventional cytology.http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1791752bladder cancercytologyurothelial carcinoma5-aminolevulinic acidsensitivityspecificity |
| spellingShingle | Rajendra B Nerli Shadab Rangrez Shridhar C. Ghagane Parth Lalakia Shoubhik Chandra Shreya Chandra 5-ALA-Induced Fluorescent Urine Cytology in Comparison with Conventional Cytology, BTA-TRAK, and NMP-22 Tests in the Diagnosis of Bladder Cancer Brazilian Journal of Oncology bladder cancer cytology urothelial carcinoma 5-aminolevulinic acid sensitivity specificity |
| title | 5-ALA-Induced Fluorescent Urine Cytology in Comparison with Conventional Cytology, BTA-TRAK, and NMP-22 Tests in the Diagnosis of Bladder Cancer |
| title_full | 5-ALA-Induced Fluorescent Urine Cytology in Comparison with Conventional Cytology, BTA-TRAK, and NMP-22 Tests in the Diagnosis of Bladder Cancer |
| title_fullStr | 5-ALA-Induced Fluorescent Urine Cytology in Comparison with Conventional Cytology, BTA-TRAK, and NMP-22 Tests in the Diagnosis of Bladder Cancer |
| title_full_unstemmed | 5-ALA-Induced Fluorescent Urine Cytology in Comparison with Conventional Cytology, BTA-TRAK, and NMP-22 Tests in the Diagnosis of Bladder Cancer |
| title_short | 5-ALA-Induced Fluorescent Urine Cytology in Comparison with Conventional Cytology, BTA-TRAK, and NMP-22 Tests in the Diagnosis of Bladder Cancer |
| title_sort | 5 ala induced fluorescent urine cytology in comparison with conventional cytology bta trak and nmp 22 tests in the diagnosis of bladder cancer |
| topic | bladder cancer cytology urothelial carcinoma 5-aminolevulinic acid sensitivity specificity |
| url | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1791752 |
| work_keys_str_mv | AT rajendrabnerli 5alainducedfluorescenturinecytologyincomparisonwithconventionalcytologybtatrakandnmp22testsinthediagnosisofbladdercancer AT shadabrangrez 5alainducedfluorescenturinecytologyincomparisonwithconventionalcytologybtatrakandnmp22testsinthediagnosisofbladdercancer AT shridharcghagane 5alainducedfluorescenturinecytologyincomparisonwithconventionalcytologybtatrakandnmp22testsinthediagnosisofbladdercancer AT parthlalakia 5alainducedfluorescenturinecytologyincomparisonwithconventionalcytologybtatrakandnmp22testsinthediagnosisofbladdercancer AT shoubhikchandra 5alainducedfluorescenturinecytologyincomparisonwithconventionalcytologybtatrakandnmp22testsinthediagnosisofbladdercancer AT shreyachandra 5alainducedfluorescenturinecytologyincomparisonwithconventionalcytologybtatrakandnmp22testsinthediagnosisofbladdercancer |